GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 diabetes patients, especially compared to insulin.
The study also highlights GLP-1RAs’ potential as a cancer-protective treatment, independent of glucose control.

Study finds link between nighttime light exposure and increased Alzheimer’s disease risk

Higher nighttime light intensity is correlated with increased Alzheimer’s disease prevalence, suggesting light pollution may influence neurodegenerative risks.

September 10, 2024

COVID Takes Center Stage at Trump Town Hall

Former President Donald Trump offered his take on the history of the COVID-19 pandemic — ranging from its origins, to lockdowns, to his relationship with

January 12, 2024

Early-Pregnancy Serial BP Measurements Can Reclassify Risk of Preeclampsia

Taking into account worrisome blood pressure (BP) patterns by the 20th week of gestation, some women may have a higher risk for hypertensive disorders of

July 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.